Where is Gritstone Bio headquartered?

Gritstone Bio is located in Emeryville, CA.

Who invested in Gritstone Bio?

Gritstone Bio has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Gritstone Bio?

Gritstone Bio closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

gritstonebio.com

Gritstone Bio

Gritstone Bio is a California-based biotechnology company that develops and commercializes immunotherapies for the treatment of cancer and infectious diseases.

Business Model:

Revenue: $18.7M

Employees: 51-200

Geographic Data

Address: 5959 Horton Street

City: Emeryville

State: CA

Zip: 94608

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$80M

Raised Total:

$476M

Social

Twitter

Crunchbase

Metrics

2,094,300Website Global Rank

9,560Website Monthly Traffic

Twitter Followers

Description

Gritstone Bio is a California-based biotechnology company that develops and commercializes immunotherapies for the treatment of cancer and infectious diseases.

Contact Phone:
+15108716100

Contact Email:

IPO Details

Gritstone Bio went public on 9/27/2018 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
9/27/2018

IPO Valuation:
$432M

Ticker Symbol:
GRTS

IPO Price:
$15/share

Amount Raised:
$100M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
10/2015	Series A	7	$102M	Clarus Ventures The Column Group Versant Ventures Transformational Healthcare Opportunity Redmile Group Frazier Healthcare Partners Casdin Capital Clarus Ventures The Column Group Versant Ventures
9/2021	Post-IPO Equity		$0	Gilead Sciences Frazier Healthcare Partners Redmile Group Gilead Sciences Frazier Healthcare Partners Redmile Group
9/2017	Series B		$92.7M	Lilly Asia Ventures GV Alexandria Venture Investments Versant Ventures The Column Group Clarus Funds
12/2020	Post-IPO Equity	5	$125M	Versant Ventures Redmile Group Biotechnology Value Fund EcoR1 Capital Avidity Partners Versant Ventures Redmile Group Biotechnology Value Fund EcoR1 Capital Avidity Partners
9/2017	Series B	9	$93M	Lilly Asia Ventures Versant Ventures Trinitas Capital The Column Group Redmile Group GV Frazier Healthcare Partners Clarus Ventures Alexandria Venture Investments Lilly Asia Ventures
6/2018	Series C	1	$21M	Redmile Group Redmile Group
10/2017	Venture Round		-	Bay City Capital Bay City Capital
7/2022	Post-IPO Debt	2	$80M	Hercules Capital Silicon Valley Bank Hercules Capital Silicon Valley Bank
9/2018	IPO		$100M
9/2021	PIPE	3	$55M	Frazier Life Sciences Public Fund Redmile Group Gilead Sciences Frazier Healthcare Partners Gilead Sciences Redmile Group
10/2017	Venture Round	1	-	Bay City Capital Bay City Capital

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details